WTD8:XETRA:XETRA-WisdomTree Issuer ICAV - WisdomTree Emerging Markets Equity Income UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 24.935

Change

-0.15 (-0.58)%

Market Cap

N/A

Volume

15.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-0.02 (-0.04%)

USD 96.80B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.77 (-0.77%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.24 (-1.00%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.02 (+0.17%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.04 (-0.67%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

N/A

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.06 (-0.47%)

USD 23.43B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.19 (-0.35%)

USD 19.49B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.07 (+0.66%)

USD 12.83B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.28 (+0.24%)

USD 12.26B

ETFs Containing WTD8:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.68% 53% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.68% 53% F 49% F
Trailing 12 Months  
Capital Gain 6.63% 54% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.63% 55% F 54% F
Trailing 5 Years  
Capital Gain 58.16% 54% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 58.16% 54% F 55% F
Average Annual (5 Year Horizon)  
Capital Gain 11.80% 69% C- 68% D+
Dividend Return 11.80% 69% C- 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.66% 60% D- 68% D+
Risk Adjusted Return 110.73% 92% A 93% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike